Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWayne State University
About this trial
The goal of this trial is to test how augmented reality exposure therapy (ARET) may potentiate the effects of traditional exposure therapy administered to U.S. military personnel diagnosed with PTSD. 40 adult males and females over the age of 18 that have served, or are currently serving, in the U.S. military, with a current diagnosis of PTSD, will be recruited. Participants will be randomized into two groups: 20 participants will receive ARET + traditional ET, with the remaining 20 to receive traditional ET only. The main questions this trial aims to answer are:
* what are the different clinical and psychosocial functioning outcomes between veterans/active-duty personnel with PTSD who receive ARET + traditional ET versus traditional ET only * what are the differences in acceptance and satisfaction of treatment, between ARET + traditional ET and the traditional ET-only group
Eligibility criteria
Qualifiers
Adult male or female over the age of 18 that has served, or is currently serving, in the military.
Current diagnosis of PTSD as determined by a Clinician Administered PTSD Scale for DSM-5 (CAPS-5) clinical interview.
Disqualifiers
Active psychosis or dementia at screening.
Suicidal ideation with clear intent.
Concurrent enrollment in another clinical trial for PTSD or depression.
Substance use disorders
Trial design
Treatments tested in this trial
- Traditional Exposure Therapy (ET) Treatment
- Stepwise Augmented Reality (AR) Component with Traditional Exposure Treatment for Nonresponders
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wayne State University
Lead sponsor
Ralph H. Johnson VA Medical Center
Collaborator
United States Department of Defense
Collaborator
Source ClinicalTrials.gov